Medical Device Company

Company Overview

12 Month Historic Financials
Revenue: $11.9M
EBITDA: $4.4M
4 year AAGR: 182%

Other
Growth Potential: high
Operational Efficiency: excellent
Transition Challenges: above average
Balance Sheet Strength: above average
Industry Expertise: high

Bid History

Bid#

Bidder Description

Offer Price and Terms

Total EV*

NPV**

1.

U.S. Private Equity Group

$15.5M cash
$2.5M – 3 year note

$18.0M

$18.0M

2.

$200M U.S. Public Co.

$15M
$5M – 5 year note
$4M – 2 year earn-out

$24.0M

$23.6M

3.

U.S. Private Equity Group

$25M cash
$5M – 3 year note

$30.0M

$30.0M

4.

$10B U.K. Private Co.

$19M cash

$19.0M

$19.0M

5.

$2B U.S. Private Co.

$25M cash
$7.95M – 3 year note

$32.95M

$32.95M

6.

$600M U.S. Private Co.

$23M cash
$6M – 3 year note

$29.0M

$29.0M

Accepted Offer:

7.

US Private Equity Group

$27.9M cash

$27.9M

$27.9M

* Enterprise Value ** Net Present Value